Big Pharma Company
May 26, 2012 at 16:42 | Source: Moneycontrol.com
May 26, 2012 at 10:37 | Source: Moneycontrol.com
May 25, 2012 at 15:54 | Source: CNBC-TV18
May 18, 2012 at 12:58 | Source: Moneycontrol.com
May 16, 2012 at 18:01 | Source: CNBC-TV18
News across the web »
May 21, 2012 at 01:46 | Source: Business Standard
Mar 28, 2012 at 11:08 | Source: Business Today
Mar 19, 2012 at 17:33 | Source: Business Today
Mar 09, 2012 at 17:16 | Source: Forbes
Feb 18, 2012 at 09:57 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
Currently, big pharma companies contribute between 10 to 25 per cent ... About Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global ...
May 25, 2012 at 11:32 | Source: Yahoo Finance
These companies are big enough to help to solve big problems in Big Pharma. “If you are a Big Pharma company facing a patent cliff, you really have a huge revenue gap to fill, and small companies don’t really help you. They aren’t ...
May 21, 2012 at 07:04 | Source: Xconomy
As patents for name brand drugs expire, generics eat into revenue, shrink earnings, and depress stock prices of the Big Pharma players ... It's no surprise that the company has lowered core 2012 EPS guidance from $6.00-$6.30 to $5.85-$6.15.
May 14, 2012 at 23:40 | Source: Jutia Group
Even if they outgrow their original diagnoses—a big “if” with a mental health history ... contacted an average of fourteen times per year by Pharma reps and were invited to attend company-continuing medical education seminars.
May 17, 2012 at 04:46 | Source: AlterNet
Ken Fisher's Fisher Asset Management is a fan of Pfizer. The fund had roughly $471.27 million invested in the company at the end of 2011 (check out Ken Fisher's top picks). But, not all big pharma companies are positioned as well. Disclosure: I have no ...
May 11, 2012 at 13:57 | Source: Seekingalpha.com
The TAC and Section 27 have joined the fray in a face-off between Aventis Pharma and Cipla Life Sciences in a patent ... the Court of the Commissioner of Patents refused the company an interim interdict to prevent Cipla from selling a generic version.
May 16, 2012 at 05:37 | Source: Mail & Guardian Online
“IMS Health, a healthcare information and services company, said that in the 12 months ending ... Of course disorders that Big Pharma has helped monetize like bipolar (which was termed “under diagnosed” and emerging in the elderly at ...
May 22, 2012 at 01:05 | Source: AlterNet
In Part I of this article, the reality of the "patent cliff" now being experienced by Big Pharma was discussed at length ... The key evaluation factor for each company going forward is: What steps are being taken to adapt to the changes all are facing ...
May 14, 2012 at 14:51 | Source: Seekingalpha.com
Icahn has since withdrawn the suit, but encouraged a sale of the company. Now, according to Bloomberg, Pfizer, AstraZeneca, Bristol-Myers, Sanofi, Merck, Roche and Takeda have signed confidentiality agreements to look at the Amylin's finances. The link to ...
May 16, 2012 at 09:55 | Source: Philadelphia Daily News
The pharma company, which is a sponsor, says it is “interested in companies pursuing innovation/opportunities related to the digital workflow of health care providers, the role of big data/real world data in health care, and how social media ...
May 15, 2012 at 22:13 | Source: Forbes